These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7685560)

  • 1. Recognition of bacterial endotoxins by receptor-dependent mechanisms.
    Ulevitch RJ
    Adv Immunol; 1993; 53():267-89. PubMed ID: 7685560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
    Ulevitch RJ; Tobias PS
    Annu Rev Immunol; 1995; 13():437-57. PubMed ID: 7542010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD11/CD18 and CD14 share a common lipid A signaling pathway.
    Ingalls RR; Monks BG; Savedra R; Christ WJ; Delude RL; Medvedev AE; Espevik T; Golenbock DT
    J Immunol; 1998 Nov; 161(10):5413-20. PubMed ID: 9820516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
    Kitchens RL; Ulevitch RJ; Munford RS
    J Exp Med; 1992 Aug; 176(2):485-94. PubMed ID: 1380063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
    Lee JD; Kato K; Tobias PS; Kirkland TN; Ulevitch RJ
    J Exp Med; 1992 Jun; 175(6):1697-705. PubMed ID: 1375269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
    Hailman E; Lichenstein HS; Wurfel MM; Miller DS; Johnson DA; Kelley M; Busse LA; Zukowski MM; Wright SD
    J Exp Med; 1994 Jan; 179(1):269-77. PubMed ID: 7505800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation.
    Tobias PS; Ulevitch RJ
    Immunobiology; 1993 Apr; 187(3-5):227-32. PubMed ID: 7687234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
    Mathison JC; Tobias PS; Wolfson E; Ulevitch RJ
    J Immunol; 1992 Jul; 149(1):200-6. PubMed ID: 1607653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
    Wright SD; Ramos RA; Tobias PS; Ulevitch RJ; Mathison JC
    Science; 1990 Sep; 249(4975):1431-3. PubMed ID: 1698311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
    Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
    J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation.
    Tobias PS; Mathison J; Mintz D; Lee JD; Kravchenko V; Kato K; Pugin J; Ulevitch RJ
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):239-45. PubMed ID: 1381594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.
    Schumann RR
    Res Immunol; 1992 Jan; 143(1):11-5. PubMed ID: 1373512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures.
    Weidemann B; Brade H; Rietschel ET; Dziarski R; Bazil V; Kusumoto S; Flad HD; Ulmer AJ
    Infect Immun; 1994 Nov; 62(11):4709-15. PubMed ID: 7523297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD14 and other recognition molecules for lipopolysaccharide: a review.
    Kielian TL; Blecha F
    Immunopharmacology; 1995 Apr; 29(3):187-205. PubMed ID: 7542643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein.
    Schletter J; Brade H; Brade L; Krüger C; Loppnow H; Kusumoto S; Rietschel ET; Flad HD; Ulmer AJ
    Infect Immun; 1995 Jul; 63(7):2576-80. PubMed ID: 7540597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide.
    Lynn WA; Liu Y; Golenbock DT
    Infect Immun; 1993 Oct; 61(10):4452-61. PubMed ID: 7691750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide.
    Ingalls RR; Golenbock DT
    J Exp Med; 1995 Apr; 181(4):1473-9. PubMed ID: 7535339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes.
    Wright SD; Ramos RA; Patel M; Miller DS
    J Exp Med; 1992 Sep; 176(3):719-27. PubMed ID: 1380975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
    Theofan G; Horwitz AH; Williams RE; Liu PS; Chan I; Birr C; Carroll SF; Mészáros K; Parent JB; Kasler H
    J Immunol; 1994 Apr; 152(7):3623-9. PubMed ID: 7511654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.